Trial Details
COMPLETEDBasic Information
| Clinical ID | c2064 |
|---|---|
| Identifier | NCT04026113 |
| Trial Title | Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Functional Constipation|Irritable Bowel Syndrome With Constipation |
| Interventions | DRUG: Linaclotide|DRUG: Placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2019-10-01 |
|---|---|
| Primary Completion Date | 2024-05-20 |
| Completion Date | 2024-05-29 |